US Stock MarketDetailed Quotes

Picard Medical (PMI)

Watchlist
  • 0.1671
  • +0.0090+5.69%
Close May 14 16:00 ET
  • 0.1692
  • +0.0021+1.26%
Post 19:25 ET
12.60MMarket Cap-0.46P/E (TTM)

Picard Medical (PMI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-31.98%-15.67M
-38.82%-4.38M
-149.77%-6.51M
34.15%-2.54M
0.62%-2.24M
-11.67%-11.88M
18.34%-3.15M
-8.26%-2.61M
-94.21%-3.86M
5.13%-2.26M
Net income from continuing operations
-28.25%-27M
51.45%-4.29M
-68.00%-10.43M
-65.74%-6.72M
-184.60%-5.56M
-35.24%-21.06M
-47.50%-8.84M
-88.86%-6.21M
-38.13%-4.06M
41.74%-1.95M
Operating gains losses
117.53%9.33M
-40.42%2.29M
1,093.42%4.54M
--776K
--1.73M
7,298.28%4.29M
--3.85M
--380K
----
----
Depreciation and amortization
-5.71%512K
3.17%130K
4.10%127K
-17.65%126K
-9.15%129K
-7.18%543K
-12.50%126K
-15.28%122K
6.25%153K
-7.19%142K
Other non cash items
89.33%4.53M
-99.91%1K
86.41%2.15M
--2.11M
--266K
--2.39M
--1.17M
--1.16M
----
----
Change In working capital
-432.50%-3.2M
-295.57%-1.5M
-448.46%-3.29M
410.62%848K
255.27%736K
-70.64%963K
-67.53%767K
315.42%943K
-250.83%-273K
-192.94%-474K
-Change in receivables
-203.45%-120K
12,850.00%259K
141.42%408K
-918.35%-1.29M
337.56%506K
-54.15%116K
100.36%2K
-75.58%169K
161.72%158K
-157.57%-213K
-Change in inventory
129.32%390K
-299.62%-531K
141.05%266K
257.24%901K
34.40%-246K
-198.21%-1.33M
-75.66%266K
46.49%-648K
-518.25%-573K
19.35%-375K
-Change in prepaid assets
-247.22%-250K
-160.67%-145K
-1,168.18%-235K
215.91%102K
111.43%28K
-160.00%-72K
305.08%239K
-73.49%22K
-4.76%-88K
-495.16%-245K
-Change in payables and accrued expense
-211.33%-2.85M
-384.29%-995K
-348.33%-3.63M
217.78%1.23M
51.81%545K
-23.65%2.56M
-80.15%350K
120.66%1.46M
1.04%388K
-33.89%359K
-Change in other current liabilities
-19.61%-372K
2.22%-88K
-21.05%-92K
34.48%-95K
---97K
---311K
---90K
---76K
---145K
--0
Cash from discontinued investing activities
Operating cash flow
-31.99%-15.67M
-38.86%-4.38M
-149.77%-6.51M
34.15%-2.54M
0.62%-2.24M
-11.66%-11.87M
18.36%-3.15M
-8.26%-2.61M
-94.21%-3.86M
5.13%-2.26M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
Net PPE purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
130.63%27.08M
302.63%13.02M
254.00%8.95M
-35.50%2.28M
15.77%2.83M
8.31%11.74M
-10.12%3.23M
22.84%2.53M
39.16%3.53M
-7.52%2.45M
Net issuance payments of debt
-5.27%11.12M
348.65%14.51M
-377.29%-7.01M
-63.39%1.29M
-4.66%2.33M
43.36%11.74M
-10.12%3.23M
22.84%2.53M
39.16%3.53M
81,700.00%2.45M
Net common stock issuance
--17.44M
--0
--15.96M
--985K
--500K
--0
--0
--0
--0
--0
Net preferred stock issuance
----
----
----
----
----
--0
--0
--0
--0
--0
Net other financing activities
---1.49M
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
130.63%27.08M
302.63%13.02M
254.00%8.95M
-35.50%2.28M
15.77%2.83M
8.31%11.74M
-10.12%3.23M
22.84%2.53M
39.16%3.53M
-7.52%2.45M
Net cash flow
Beginning cash position
-60.66%96K
46,783.33%2.81M
425.64%410K
67.80%688K
-60.66%96K
60.53%244K
-98.69%6K
-91.96%78K
16.15%410K
60.53%244K
Current changes in cash
8,675.19%11.41M
10,566.67%8.64M
3,143.75%2.44M
19.57%-263K
207.25%593K
-167.51%-133K
130.68%81K
77.21%-80K
-159.35%-327K
-26.05%193K
Effect of exchange rate changes
-233.33%-50K
-122.22%-2K
-500.00%-32K
-200.00%-15K
96.30%-1K
85.71%-15K
-82.35%9K
104.94%8K
-107.58%-5K
55.00%-27K
End cash Position
11,828.13%11.45M
11,828.13%11.45M
46,783.33%2.81M
425.64%410K
67.80%688K
-60.66%96K
-60.66%96K
-98.69%6K
-91.96%78K
16.15%410K
Free cash flow
-31.99%-15.67M
-38.86%-4.38M
-149.77%-6.51M
34.15%-2.54M
0.62%-2.24M
-11.59%-11.87M
18.36%-3.15M
-8.26%-2.61M
-94.21%-3.86M
5.41%-2.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -31.98%-15.67M-38.82%-4.38M-149.77%-6.51M34.15%-2.54M0.62%-2.24M-11.67%-11.88M18.34%-3.15M-8.26%-2.61M-94.21%-3.86M5.13%-2.26M
Net income from continuing operations -28.25%-27M51.45%-4.29M-68.00%-10.43M-65.74%-6.72M-184.60%-5.56M-35.24%-21.06M-47.50%-8.84M-88.86%-6.21M-38.13%-4.06M41.74%-1.95M
Operating gains losses 117.53%9.33M-40.42%2.29M1,093.42%4.54M--776K--1.73M7,298.28%4.29M--3.85M--380K--------
Depreciation and amortization -5.71%512K3.17%130K4.10%127K-17.65%126K-9.15%129K-7.18%543K-12.50%126K-15.28%122K6.25%153K-7.19%142K
Other non cash items 89.33%4.53M-99.91%1K86.41%2.15M--2.11M--266K--2.39M--1.17M--1.16M--------
Change In working capital -432.50%-3.2M-295.57%-1.5M-448.46%-3.29M410.62%848K255.27%736K-70.64%963K-67.53%767K315.42%943K-250.83%-273K-192.94%-474K
-Change in receivables -203.45%-120K12,850.00%259K141.42%408K-918.35%-1.29M337.56%506K-54.15%116K100.36%2K-75.58%169K161.72%158K-157.57%-213K
-Change in inventory 129.32%390K-299.62%-531K141.05%266K257.24%901K34.40%-246K-198.21%-1.33M-75.66%266K46.49%-648K-518.25%-573K19.35%-375K
-Change in prepaid assets -247.22%-250K-160.67%-145K-1,168.18%-235K215.91%102K111.43%28K-160.00%-72K305.08%239K-73.49%22K-4.76%-88K-495.16%-245K
-Change in payables and accrued expense -211.33%-2.85M-384.29%-995K-348.33%-3.63M217.78%1.23M51.81%545K-23.65%2.56M-80.15%350K120.66%1.46M1.04%388K-33.89%359K
-Change in other current liabilities -19.61%-372K2.22%-88K-21.05%-92K34.48%-95K---97K---311K---90K---76K---145K--0
Cash from discontinued investing activities
Operating cash flow -31.99%-15.67M-38.86%-4.38M-149.77%-6.51M34.15%-2.54M0.62%-2.24M-11.66%-11.87M18.36%-3.15M-8.26%-2.61M-94.21%-3.86M5.13%-2.26M
Investing cash flow
Cash flow from continuing investing activities 00000
Net PPE purchase and sale ----------------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 130.63%27.08M302.63%13.02M254.00%8.95M-35.50%2.28M15.77%2.83M8.31%11.74M-10.12%3.23M22.84%2.53M39.16%3.53M-7.52%2.45M
Net issuance payments of debt -5.27%11.12M348.65%14.51M-377.29%-7.01M-63.39%1.29M-4.66%2.33M43.36%11.74M-10.12%3.23M22.84%2.53M39.16%3.53M81,700.00%2.45M
Net common stock issuance --17.44M--0--15.96M--985K--500K--0--0--0--0--0
Net preferred stock issuance ----------------------0--0--0--0--0
Net other financing activities ---1.49M------------------------------------
Cash from discontinued financing activities
Financing cash flow 130.63%27.08M302.63%13.02M254.00%8.95M-35.50%2.28M15.77%2.83M8.31%11.74M-10.12%3.23M22.84%2.53M39.16%3.53M-7.52%2.45M
Net cash flow
Beginning cash position -60.66%96K46,783.33%2.81M425.64%410K67.80%688K-60.66%96K60.53%244K-98.69%6K-91.96%78K16.15%410K60.53%244K
Current changes in cash 8,675.19%11.41M10,566.67%8.64M3,143.75%2.44M19.57%-263K207.25%593K-167.51%-133K130.68%81K77.21%-80K-159.35%-327K-26.05%193K
Effect of exchange rate changes -233.33%-50K-122.22%-2K-500.00%-32K-200.00%-15K96.30%-1K85.71%-15K-82.35%9K104.94%8K-107.58%-5K55.00%-27K
End cash Position 11,828.13%11.45M11,828.13%11.45M46,783.33%2.81M425.64%410K67.80%688K-60.66%96K-60.66%96K-98.69%6K-91.96%78K16.15%410K
Free cash flow -31.99%-15.67M-38.86%-4.38M-149.77%-6.51M34.15%-2.54M0.62%-2.24M-11.59%-11.87M18.36%-3.15M-8.26%-2.61M-94.21%-3.86M5.41%-2.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion------------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More